7Burckhardt Ringe M.D.,Rudolf Pichlmayr M.D.,Christian Wittekind M.D.,Günter Tusch M.S.. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients[J] 1991,World Journal of Surgery(2):270～285
二级参考文献47
1Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量：214
6American Joint Committee on Cancer. Manual for staging of cancer. Philadelphia: J B Lippincott, 1998.87-92.
7Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med, 1996, 334( 11 ): 693 -699.
8Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology, 2001,33(6):1394-1403.
9Marsh JW, Dvorchik I, Bonham CA, et al. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer, 2000, 88(3):538-543.
10United Netwerk for Organ Sharing. Liver transplan candidates with hepatocellular carcinoma (HCC). Policy, 2002,3(6):40-44.
4fftikhar R, Kladney RD, Havlioglu N, et al. Disease - and cell - apecifie expression of GP73 in human liver disease[ J]. Am J Gas- troenterol, 2004,99 ( 6 ) : 1087 - 1095.
5Debruyne EN, Delanghe JR. Diagnosing and monitoring hepatocel- lular carcinoma with alpha - fetoprotein : new aspects and applica- tions [ J ]. Clin Chim Acta,2008,395 ( 1 - 2 ) : 19 - 26.
6Cheng H T, Chang Y H, Chen Y Y,et al. AFP - L3 in chronic liver diseases with persistent elevation of alpha - fetoprotein [ J ]. J Chin Med Assoc,2007,70(8) :310 -317.
7Hippo Y, Watanabe K, Watanabe A, et al. Identification of solu- ble NH2 - terminal fragment of glypican - 3 as a serological marker for early- stage hepatocellular carcinoma [ J ]. Cancer Res, 2004, 64(7) : 2418 -2423.
8Yamauchi N, Watanabe A, Hishinuma M, et al. The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellu- lar carcinoma[ J]. Mod Pathol,2005,18 ( 12 ) : 1591 - 1598.
9Sakamoto M, Moil T, Masugi Y, et al. Candidate molecular mark- ers for histological diagnosis of early hepatocellular carcinoma [ J]. Intervirology,2008,51 Suppl 1:42 -45.
10Lok AS, Stealing RK, Everhart JE, et al. Des - gamma - carboxy Prothrombin and Alpha - fetoprotein as Biomarkers for the early detection of hepatocellular carcinoma[ J ]. Gastroenterology,2010, 138(2) :493 -502.
